Jade Biosciences Inc. (AVTE)
NASDAQ · Healthcare
Jade Biosciences Inc. Long Term Debt 2019–2024
Jade Biosciences Inc. annual long term debt history from 2019 to 2023. Long term debt refers to financial obligations that are due more than one year in the future.
- Jade Biosciences Inc. long term debt as of December 31, 2023: 255,000, a 63.83% decrease year-over-year.
- Jade Biosciences Inc. long term debt for 2023 were 255,000, a 63.83% decrease from 2022.
- Jade Biosciences Inc. long term debt for 2022 were 705,000, a 84.55% increase from 2021.
- Jade Biosciences Inc. long term debt for 2021 were 382,000, a 84.72% decrease from 2019.
- Jade Biosciences Inc. long term debt for 2019 were 2.5M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Jade Biosciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2023 | $0 |
| 2022 | $1 |
| 2021 | $0 |
| 2019 | $3 |
Jade Biosciences Inc. Long Term Debt — FAQ
Jade Biosciences Inc. (AVTE) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTE's long term debt history?
The chart and table above show Jade Biosciences Inc.'s long term debt by year and by quarter, including the growth rate.